Biomarkers in blood could aid diagnosis of crippling, often fatal forms of malaria

December 08, 2008

Canadian researchers to describe double malaria breakthrough in New Orleans

Canadian researchers have identified protein biomarkers that shed new light on the development of two severe and debilitating forms of malaria.

The findings may let doctors detect earlier two crippling malaria variations - one that develops in the placenta of pregnant women affecting countless unborn children, the other, cerebral malaria, that develops in the brain's blood vessels - malaria's most deadly form.

The double breakthrough will be described at annual meetings of the American Society of Tropical Medicine and Hygiene in New Orleans, Louisiana, USA, Dec. 7-11, 2008.

Over-activation of body's natural defences implicated in placental malaria

Tropical disease specialists affiliated with Toronto's McLaughlin-Rotman Centre for Global Health (MRC) say malaria has notoriously stalked pregnant women through the ages.

Many women growing up in areas such as sub-Saharan Africa gradually develop partial immunity to malaria and become relatively impervious to it until their first pregnancy. Often, the expectant mother with placental malaria appears relatively well and the disease is detected only after the child is delivered.

Some 10,000 women die annually from placental malaria, while up to 400,000 develop severe anemia. The disease also causes up to 200,000 infant deaths and countless cases of babies born with low birth weight - a major risk factor for early childhood death.

A decade ago, researchers showed malaria parasites can accumulate in the newly created placenta. But how parasites hiding in the placenta actually result in placental and fetal injury was unclear, says lead researcher and Dr. Kevin Kain, Director of the Sandra A. Rotman Laboratories at the MRC.

Dr. Kain, in collaboration with W. Conrad Liles and colleagues Andrea Conroy, Lena Serghides, Constance Finney, Simon O. Owino, Sanjeev Kumar, D. Channe Gowda, and Julie M. Moore say their work unravels part of this mystery.

They found that women with placental malaria carry a biomarker in their blood -- a protein called C5a, which is an important part of the body's innate defence against infections but one that needs to be carefully controlled.

When overactived by malaria infection, C5a appears to contribute to an excessive inflammatory response and dysrupts normal blood vessel growth in the placenta, raising the risk of spontaneous abortions or low birth weight infants.

Tests on pregnant women in Kenya revealed that those with placental malaria had elevated levels of C5a in their blood compared to expectant mothers without the disease. The discovery may help identify placental malaria carriers early enough to potentially prevent tragic consequences through better targeted treatment strategies.

"Children born with low birth weight from placental malaria have several strikes against them before they've drawn a breath," says Dr. Kain, who is also Director of the Center for Travel and Tropical Medicine at Toronto General Hospital. "Any additional illness that comes along in early childhood is more likely to kill them."

"A test that helps detect placental malaria means women can be treated earlier pregnancy, reducing the risk of death or anemia for them, and perhaps saving their babies from malformation or miscarriage."

Protein "biomarker" linked to cerebral malaria, predicts survival

Meanwhile, Drs. Kain and Liles, with colleagues Fiona E. Lovegrove, Erin I. Lafferty, Nimerta Rajwans, and Michael Hawkes, together with collaborators from Thailand, Noppadon Tangpukdee Srivicha Krudsood, Sornchai Looareesuwan, and Uganda, Robert O. Opoka and Chandy C. John, will report in New Orleans on a similar breakthrough: biomarkers that reveal potential victims of cerebral malaria, the disease's most fatal form.

Cerebral malaria is a scourge of people with little developed immunity, affecting particularly African children under five years old and other non-immune adults and travellers to developing countries. It kills 10 to 40% of its victims.

Some 2 to 5% of children with malaria develop the cerebral form. Millions of invading parasites damage the blood vessels of the brain resulting in coma and frequently death. Surprisingly, those who survive it emerge relatively intact neurologically.

Blood tests on patients with cerebral malaria were compared with samples from patients with uncomplicated malaria and from healthy test control subjects.

Cerebral malaria patients were found to have abnormal levels of proteins that regulate the activation of blood vessels known as angiopoietins. Angiopoietin-1 (ANG-1) and angiopoietin-2 (ANG-2) must be in careful balance to maintain healthly endothelial cells that line blood vessels.

In cerebral malaria, the research showed ANG-1 and ANG-2 were dysregulated, likely contributing to excessive activation of the endothelial cells and parasite obstruction of brain blood vessels, associated with cerebral malaria.

High levels of ANG-2 and low levels of ANG-1 were associated with the severity of disease; the levels recorded on admission to hospital predicted which children would subsequently die.

The accuracy of ANG-1 and ANG-2 levels in identifying cerebral malaria was very high (80 to 100%; in African children and Thai adults respectively)

The finding could help doctors spot at-risk individuals early in the course of the disease, with profound implications for triaging critically ill children in developing countries and effectively allocating scarce health care resources. Furthermore, drugs or agents that block ANG-2 or enhance ANG-1 may have a therapeutic role in preventing or treating cerebral malaria.

Says Dr. Liles: "While there is still much work ahead related to this finding, we believe it could soon help improve priority setting by doctors as they decide which patients need the most intensive anti-malaria therapy and supportive care once symptoms are detected."

Program on Life Sciences, Ethics and Policy,McLaughlin-Rotman Centre for Global Health

---

---

	End Malaria by Michael Bungay Stanier (Editor) End Malaria is more than a book, it’s a great cause. At least $20 from each copy sold by us goes directly to Malaria No More to send a mosquito net to a family in need and to support life-saving work in the fight against malaria. Malaria No More, an international advocacy organization, is on a mission to end malaria related deaths by 2015. In addition to saving lives, buying this book means you can enjoy essays by 62 of American’s favorite business authors, including Tom Peters, Nicholas Carr, Pam Slim, and Sir Ken Robinson. Organized into three main sections—Focus, Courage, Resilience—and eight subsections—Tap Your Strengths, Create Freedom, Love & Be Kind, Disrupt Normal, Take Small Steps, Embrace Systems, Get Physical, Collaborate—all essays in End...
	The Making of a Tropical Disease: A Short History of Malaria (Johns Hopkins Biographies of Disease) by Randall M. Packard (Author) Malaria sickens hundreds of millions of people—and kills one to three million—each year. Despite massive efforts to eradicate the disease, it remains a major public health problem in poorer tropical regions. But malaria has not always been concentrated in tropical areas. How did other regions control malaria and why does the disease still flourish in some parts of the globe?From Russia to Bengal to Palm Beach, Randall Packard’s far-ranging narrative traces the natural and social forces that help malaria spread and make it deadly. He finds that war, land development, crumbling health systems, and globalization—coupled with climate change and changes in the distribution and flow of water—create conditions in which malaria's carrier mosquitoes thrive. The combination of these...
	The Fever: How Malaria Has Ruled Humankind for 500,000 Years by Sonia Shah (Author) In recent years, malaria has emerged as a cause célèbre for voguish philanthropists. Bill Gates, Bono, and Laura Bush are only a few of the personalities who have opened their pocketbooks in hopes of eradicating the scourge. How does a parasitic disease that we’ve known how to prevent for more than a century still infect three hundred million people every year, killing nearly one million of them? In The Fever, the journalist Sonia Shah sets out to answer this question, delivering a timely, inquisitive chronicle of the illness and its influence on human lives. The Fever captures the curiously fascinating, devastating history of this long-standing thorn in the side of humanity.
	The Imaginations of Unreasonable Men: Inspiration, Vision, and Purpose in the Quest to End Malaria by Bill Shore (Author) A small cadre of scientists—collaborators and competitors—are determined to develop a vaccine for malaria—a feat most tropical disease experts have long considered impossible. Skepticism, doubt, and a host of logistical and financial obstacles dog their quest. Success may ultimately elude them. Why, and how, do they persist? Bill Shore is a writer, philanthropist, and business leader who knows from personal experience the rare and elusive nature of transformative innovation. In this moving and inspiring book, the story of these uncompromising scientists serves as springboard for his passionate inquiry into the character and moral fabric of those who devote their lives to solving the world’s most pressing and perplexing problems. What does it take to achieve the impossible? It takes...
	The Malaria Capers : More Tales of Parasites and People, Research and Reality by Robert S. Desowitz (Author) "Reads like a murder mystery. . . . [Desowitz] writes with uncommon lucidity and verse, leaving the reader with a vivid understanding of malaria and other tropical diseases, and the ways in which culture, climate and politics have affected their spread and containment."—New York TimesWhy, Robert S. Desowitz asks, has biotechnical research on malaria produced so little when it had promised so much? An expert in tropical diseases, Desowtiz searches for answers in this provocative book.
	Little Things Make Big Differences: A Story about Malaria by John Nunes (Author)
	Quinine: Malaria and the Quest for a Cure That Changed the World by Fiammetta Rocco (Author) Quinine: The Jesuits discovered it. The Protestants feared it. The British vied with the Dutch for it, and the Nazis seized it. Because of quinine, medicine, warfare, and exploration were changed forever. For more than one thousand years, there was no cure for malaria. In 1623, after ten cardinals and hundreds of their attendants died in Rome while electing Urban VII the new pope, he announced that a cure must be found. He encouraged Jesuit priests establishing new missions in Asia and in South America to learn everything they could about how the local people treated the disease, and in 1631, an apothecarist in Peru named Agostino Salumbrino dispatched a new miracle to Rome. The cure was quinine, an alkaloid made from the bitter red bark of the cinchona tree. From the quest of the...
	Humanity's Burden: A Global History of Malaria (Studies in Environment and History) by James L.A. Webb Jr. (Author) Humanity's Burden provides a panoramic overview of the history of malaria. It traces the long arc of malaria out of tropical Africa into Eurasia, its transfer to the Americas during the early years of the Columbian exchange, and its retraction from the middle latitudes into the tropics since the late nineteenth century. Adopting a broadly comparative approach to historical patterns and processes, it synthesizes research findings from the natural and social sciences and weaves these understandings into a narrative that reaches from the earliest evidence of malaria infections in tropical Africa up to the present. Written in a style that is easily accessible to non-specialists, it considers the significance of genetic mutations, diet, lifestyle, migration, warfare, palliative and curative...
	Molecular Approaches to Malaria: by Irwin W. Sherman (Editor) "Molecular Approaches to Malaria" provides an overview of the rapid and significant developments that have occurred in malaria research, including the 2002 genome sequencing of Plasmodium falciparum and its mosquito vector, Anopheles gambiae. This work: provides a concise source of up-to-date research findings; appeals to a diverse audience, including malaria researchers, teachers, investigators, and public health professionals; offers contributions by recognized malaria researchers with practical experience; and, presents comprehensive coverage of topics including a clearly written introduction to Plasmodium molecular biology.
	Understanding Malaria: Fighting an Ancient Scourge Malaria is a disease caused by a parasite* that lives part of its life in humans and part in mosquitoes. Malaria remains one of the major killers of humans worldwide, threatening the lives of more than one-third of the world’s population. It thrives in the tropical areas of Asia, Africa, and Central and South America, where it strikes millions of people. Each year 350 to 500 million cases of malaria occur worldwide. Sadly, more than 1 million of its victims, mostly young children, die yearly. Although malaria has been virtually eradicated in the United States and other regions with temperate climates, it continues to affect hundreds of people in this country every year. The Centers for Disease Control and Prevention (CDC) estimates 1,200 cases of malaria are diagnosed each...